Harmony Bio’s Zynerba Buyout Brings Cannabinoid That Doesn’t Spark Euphoria
Zynerba Pharmaceuticals’ lead drug candidate is designed to bring the therapeutic effect of cannabinoids without also causing euphoric effects. The synthetic cannabinoid in a topical gel formulation includes none of the psychoactive compounds from the cannabis plant.